{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:19:36Z","timestamp":1789107576513,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajogmf.2024.101568","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T06:37:34Z","timestamp":1732430254000},"page":"101568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["Aspirin dosage for preeclampsia prophylaxis: an argument for 81-mg dosing"],"prefix":"10.1016","volume":"7","author":[{"given":"Kimen S.","family":"Balhotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baha M.","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2024.101568_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0003","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/AOG.0000000000002709","article-title":"ACOG committee opinion no. 743 summary: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0004","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0143-4004(91)90339-H","article-title":"Current topic: pre-eclampsia and the placenta","volume":"12","author":"Redman","year":"1991","journal-title":"Placenta"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0006","first-page":"467","article-title":"Pre-eclampsia: pathophysiology, diagnosis, and management","volume":"7","author":"Uzan","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0007","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0002-9378(12)90917-5","article-title":"Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials","volume":"168","author":"Dekker","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0008","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199110173251605","article-title":"Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin","volume":"325","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0009","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9378(85)80223-4","article-title":"Preeclampsia: an imbalance in placental prostacyclin and thromboxane production","volume":"152","author":"Walsh","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","article-title":"Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae","volume":"1","author":"Wallenburg","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0012","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. the National Institute of Child Health and Human Development network of maternal-fetal medicine units","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0013","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0014","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09513.x","article-title":"ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (estudo colaborativo para prevencao da pre-eclampsia com aspirina) collaborative group","volume":"103","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","article-title":"Barbados low dose aspirin study in pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications","volume":"105","author":"Rotchell","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0016","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (collaborative low-dose aspirin study in pregnancy) collaborative group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A randomised trial of low dose aspirin for primiparae in pregnancy","volume":"105","author":"Golding","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0018","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0019","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"Henderson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0021","doi-asserted-by":"crossref","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","article-title":"Prevention of preeclampsia with aspirin","volume":"226","author":"Rolnik","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0022","series-title":"WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia","year":"2021"},{"issue":"Suppl1","key":"10.1016\/j.ajogmf.2024.101568_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0024","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1136\/heartjnl-2011-300949","article-title":"Hypertension in pregnancy: the NICE guidelines","volume":"97","author":"Redman","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101000","article-title":"Comparing aspirin 75\u201381 mg vs 150\u2013162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","volume":"5","author":"Ghesquiere","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0026","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/jch.14821","article-title":"The optimal dosage of aspirin for preventing preeclampsia in high-risk pregnant women: a network meta-analysis of 23 randomized controlled trials","volume":"26","author":"Hu","year":"2024","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0027","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0028","unstructured":"Comparing two aspirin doses to help prevent high blood pressure in pregnancy. Available at: https:\/\/www.pcori.org\/research-results\/2023\/comparing-two-aspirin-doses-help-prevent-high-blood-pressure-pregnancy."},{"key":"10.1016\/j.ajogmf.2024.101568_bib0029","first-page":"1039","article-title":"ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, october 2006: postpartum hemorrhage","volume":"108","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0030","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0015-0282(99)00088-6","article-title":"Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay","volume":"71","author":"Rubinstein","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0031","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/AOG.0000000000000736","article-title":"Low-dose aspirin and preterm birth: a randomized controlled trial","volume":"125","author":"Silver","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0032","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0033","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/AOG.0000000000001301","article-title":"Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses","volume":"127","author":"Ahrens","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0034","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0035","article-title":"Neurodevelopment of children whose mothers were randomized to low-dose aspirin during pregnancy","author":"Hoffman","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0036","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0037","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0038","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0039","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks&apos; gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0041","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/HYPERTENSIONAHA.109.134825","article-title":"Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines","volume":"54","author":"Snoep","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0042","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0043","first-page":"B2","article-title":"Society for Maternal-Fetal Medicine special statement: prophylactic low-dose aspirin for preeclampsia prevention\u2014quality metric and opportunities for quality improvement","volume":"229","author":"Combs","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0044","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0140-6736(90)91377-M","article-title":"Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension","volume":"335","author":"McParland","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-9378(93)90351-I","article-title":"Low-dose aspirin therapy to prevent preeclampsia","volume":"168","author":"Hauth","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0046","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0047","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0048","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2017.12.238","article-title":"Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0049","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ajog.2015.01.013","article-title":"The potential perinatal origin of placentation disorders in the young primigravida","volume":"212","author":"Brosens","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201dGreat obstetrical syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0051","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.semperi.2014.03.001","article-title":"Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption","volume":"38","author":"Ananth","year":"2014","journal-title":"Semin Perinatol"},{"issue":"Suppl","key":"10.1016\/j.ajogmf.2024.101568_bib0052","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","article-title":"Why is placentation abnormal in preeclampsia?","volume":"213","author":"Fisher","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0053","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ajogmf.2024.101568_bib0054","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9378(80)90387-7","article-title":"The human placental bed: electron microscopic study of trophoblastic invasion of spiral arteries","volume":"137","author":"De Wolf","year":"1980","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933324002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933324002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T12:06:31Z","timestamp":1744977991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933324002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2589933324002945"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101568","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin dosage for preeclampsia prophylaxis: an argument for 81-mg dosing","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101568"}}